Clairus Hints at Collaboration with Ivy League Lab in Q4 | GenomeWeb

WASHINGTON, DC, Oct. 3 – Clairus Technologies said that it is set to sign a letter of intent with an Ivy League university in the US to collaborate research on certain genomic-based diagnostic products, a company official said on Wednesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.